REFERENCES
  1. Vaiman M, Lazarovitch T, Heller L, Lotan G. Ecthyma gangrenosum and ecthyma-like lesions: review article. Eur J Clin Microbiol Infect Dis . 2015;34(4):633‐639. doi:10.1007/s10096-014-2277-6
  2. Pacha O, Hebert AA. Ecthyma gangrenosum and neutropenia in a previously healthy child. Pediatr Dermatol . 2013;30(6):e283-e284. doi:10.1111/j.1525-1470.2012.01726.x
  3. Goolamali SI, Fogo A, Killian L, et al. Ecthyma gangrenosum: an important feature of pseudomonal sepsis in a previously well child. Clin Exp Dermatol . 2009;34(5):e180-e182. doi:10.1111/j.1365-2230.2008.03020.x
  4. Bucak IH, Tümgör G, Mengen E, Temiz F, Turgut M. Ecthyma gangrenosum in a previously healthy pediatric patient and associated facial paralysis and persistent hyperplastic primary vitreous. Am J Case Rep . 2012;13:250-253. doi:10.12659/AJCR.883503
  5. O’Sullivan GM, Worsnop F, Natkunarajah J. Ecthyma gangrenosum, an important cutaneous infection to recognize in the immunosuppressed patient. Clin Exp Dermatol . 2018;43(1):67‐69. doi:10.1111/ced.13253
  6. Ungaro R and Mikulska M. The skin and soft tissue infections in hematological patients Curr Opin Infect Dis 2020; 33:101–109 doi:10.1097/QCO.0000000000000632
  7. Martínez-Longoria CA, Rosales-Solis GM, Ocampo-Garza J, Guerrero-González GA, Ocampo-Candiani J. Ecthyma gangrenosum: a report of eight cases. An Bras Dermatol . 2017;92(5):698‐700. doi:10.1590/abd1806-4841.20175580
  8. Shah M, Crane JS. Ecthyma Gangrenosum. In: StatPearls . Treasure Island (FL): StatPearls Publishing; 2020.
  9. Wuyts L, Wojciechowski M, Maes P, Matthieu L, Lambert J, Aerts O. Juvenile ecthyma gangrenosum caused by Pseudomonas aeruginosa revealing an underlying neutropenia: case report and review of the literature. J Eur Acad Dermatol Venereol . 2019;33(4):781‐785. doi:10.1111/jdv.15420
  10. Korte AKM, Vos JM.N Ecthyma Gangrenosum. New Engl J Med. 2017 Dec 7;377(23):e32. doi: 10.1056/NEJMicm1702302.
  11. Chan Y H, Chong C Y, Puthucheary J, Loh T F Ecthyma gangrenosum: a manifestation of Pseudomonas sepsis in three paediatric patients. Singapore Med J 2006; 47(12) : 1080
  12. Gargouri L, Maaloul I, Kamoun T, et al. Ecthyma gangrenosum: A manifestation of community-acquired Pseudomonas aeruginosa septicemia in three infants. Arch Pediatr . 2015;22(6):616‐620. doi:10.1016/j.arcped.2015.03.006
  13. Fang LC, Peng CC, Chi H, Lee KS, Chiu NC. Pseudomonas aeruginosa sepsis with ecthyma gangrenosum and pseudomembranous pharyngolaryngitis in a 5-month-old boy. J Microbiol Immunol Infect . 2014;47(2):158‐161. doi:10.1016/j.jmii.2012.05.010
  14. Mishra K, Yanamandra U, Prakash G, Malhotra P. Ecthyma gangrenosum in a case of acute lymphoblastic lymphoma. BMJ Case Rep . 2017;2017:bcr2016218501. Published 2017 Jan 4. doi:10.1136/bcr-2016-218501
  15. Kikuchi N, Nakao H, Matsumoto Y, Yoshida K, Okai M, Kawai T, Kubota M, Ishiguro A. Ecthyma gangrenosum in an infant with neutropenia. Int J Hematol. 2021 Jan;113(1):3-4. doi: 10.1007/s12185-020-03037-y. Epub 2020 Nov 24. PMID: 33236272
  16. Saade A, Mirouse A, Zafrani L. Ecthyma gangrenosum: An early hint for diagnosis. Int J Infect Dis. 2020 Aug;97:19-20. doi: 10.1016/j.ijid.2020.05.103. Epub 2020 Jun 1. PMID: 32497813.
  17. Taplitz RA, Kennedy EB, Bow EJ, et al. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. J Clin Oncol . 2018;36(30):3043‐3054. doi:10.1200/JCO.18.00374
  18. Rodrigues A, Gomes A, Marçal PH, Dias-Souza MV. Dexamethasone abrogates the antimicrobial and antibiofilm activities of different drugs against clinical isolates of Staphylococcus aureus  and Pseudomonas aeruginosaJ Adv Res . 2017;8(1):55‐61. doi:10.1016/j.jare.2016.12.001
  19. Joosten A, Maertens J, Verhaegen J, Lodewyck T, Vermeulen E, Lagrou K. High incidence of bloodstream infection detected by surveillance blood cultures in hematology patients on corticosteroid therapy. Support Care Cancer . 2012;20(11):3013-3017. doi:10.1007/s00520-012-1557-x
  20. Dare JM, Moppett JP, Shield JP, Hunt LP, Stevens MC. The impact of hyperglycemia on risk of infection and early death during induction therapy for acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer . 2013;60(12):E157-E159. doi:10.1002/pbc.24689
  21. Hansen BA, Wendelbo Ø, Bruserud Ø, Hemsing AL, Mosevoll KA, Reikvam H. Febrile Neutropenia in Acute Leukemia. Epidemiology, Etiology, Pathophysiology and Treatment. Mediterr J Hematol Infect Dis . 2020;12(1):e2020009. Published 2020 Jan 1. doi:10.4084/MJHID.2020.009
  22. Giordano P, Molinari AC, Del Vecchio GC, et al. Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.Am J Hematol 2010; 85: 325-30
  23. Llamas-Velasco M, Alegría V, Santos-Briz Á, Cerroni L, Kutzner H, Requena L. Occlusive Nonvasculitic Vasculopathy. Am J Dermatopathol . 2017;39(9):637‐662. doi:10.1097/DAD.0000000000000766
  24. Conter V, Colombini A. Trattamento della leucemia linfoblastica acuta negli adolescenti: risultati e tossicità Clinica Pediatrica, Università Milano Bicocca, Ospedale San Gerardo, Monza (MB), Italy.Libro degli abstract XL Congresso Nazionale AIEOP p 91-92
  25. Möricke A, Zimmermann M, Valsecchi MG,et al. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. Blood. 2016 Apr 28;127(17):2101-12. doi: 10.1182/blood-2015-09-670729. Epub 2016 Feb 17).
  26. Ribera JM, Ribera J, Genescà E. Treatment of adolescent and young adults with acute lymphoblastic leukemia. Mediterr J Hematol Infect Dis . 2014;6(1):e2014052. Published 2014 Jul 2. doi:10.4084/MJHID.2014.052
  27. Anderson C, Lund JL, Weaver MA, Wood WA, Olshan AF, Nichols HB. Noncancer mortality among adolescents and young adults with cancer. Cancer . 2019;125(12):2107-2114. doi:10.1002/cncr.32063
  28. Duman M, Ozdemir D, Yiş U, Köroğlu TF, Oren O, Berktaş S. Multiple erythematous nodules and ecthyma gangrenosum as a manifestation of Pseudomonas aeruginosa sepsis in a previously healthy infant. Pediatr Dermatol . 2006;23(3):243‐246. doi:10.1111/j.1525-1470.2006.00226.x
  29. O’Connor D, Bate J, Wade R, et al. Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood . 2014;124(7):1056‐1061. doi:10.1182/blood-2014-03-560847
  30. Caselli D, Cesaro S, Ziino O, et al. Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation. Haematologica . 2010;95(9):1612‐1615. doi:10.3324/haematol.2009.020867
  31. Eurpean Center for disease prevention and control. Surveillance report. Surveillance of antimicrobial resistance in Europe 2018.www.ecdc.europa.eu
  32. Kuo FC, Wang SM, Shen CF, et al. Bloodstream infections in pediatric patients with acute leukemia: Emphasis on gram-negative bacteria infections. J Microbiol Immunol Infect . 2017;50(4):507-513. doi:10.1016/j.jmii.2015.08.013
  33. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis . 2014;59(2):147‐159. doi:10.1093/cid/ciu296
  34. Khalil BA, Baillie CT, Kenny SE, et al. Surgical strategies in the management of ecthyma gangrenosum in paediatric oncology patients. Pediatr Surg Int . 2008;24(7):793-797. doi:10.1007/s00383-008-2159-z
  35. Karimi K, Odhav A, Kollipara R, Fike J, Stanford C, Hall JC. Acute Cutaneous Necrosis: A Guide to Early Diagnosis and Treatment. J Cutan Med Surg . 2017;21(5):425-437. doi:10.1177/1203475417708164
  36. Persano G, Pinzauti E, Pancani S, Incerti F. Successful Use of Negative-pressure Wound Therapy and Dermal Substitute in the Treatment of Gluteal Ecthyma Gangrenosum in a 2-year-old Girl. Plast Reconstr Surg Glob Open . 2018;6(10):e1953. Published 2018 Oct 3. doi:10.1097/GOX.0000000000001953